FDA makes 3 prescription drugs available over the counter

Three drugs that were previously only available with a prescription will now be available over the counter. 

The drugs are GlaxoSmithKline's Voltaren, a gel used to relieve arthritis pain, and two versions of Alcon's Pataday, an eye drop used for allergy relief. 

"Approval of a wider range of nonprescription drugs has the potential to improve public health by increasing the types of drugs consumers can access and use that would otherwise only be available by prescription. This includes providing the millions of people that suffer with joint pain from arthritis daily over-the-counter access to another nonopioid treatment option," Karen Mahoney, MD, acting deputy director of the FDA's office of nonprescription drugs, said in a Feb. 14 news release.

For a drug to switch from prescription to over-the-counter status, the drugmaker must prove that consumers can understand how to use the drug safely and effectively without the supervision of a healthcare professional. 

All three of the drugs will now be marketed in the U.S. as nonprescription and will no longer be available as prescriptions.

Read the full news release here

More articles on pharmacy:
21 states reject $18B opioid settlement offer from McKesson, Cardinal, AmerisourceBergen
BCBS responds to physician pushback on mail-order pharmacy plan
The 20 most expensive drugs in the US in 2020

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Featured Content

Featured Webinars

Featured Whitepapers